← Open Payments lookup

KONSTANTINOS TRIPODIS: Open Payments

NPI 1588698534 · BURBANK, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$241,808 in 203 payments from 7 companies in 2025. Trend: 2023 $147,395 · 2024 $192,054 · 2025 $241,808

Speaker / faculty: $207,584Consulting: $16,640Travel & lodging: $10,624Food & beverage: $6,960
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.62$84,824
Neurocrine BioSciences, Inc.54$67,322
Otsuka America Pharmaceutical, Inc.29$42,479
Alkermes, Inc.25$24,495
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)28$22,439
E.R. Squibb & Sons, L.L.C.4$222
Lundbeck LLC1$25

Products named: UZEDY, INGREZZA, ABILIFY MAINTENA, LYBALVI, CAPLYTA, COBENFY, ARISTADA, ABILIFY ASIMTUFII.

Industry payments across CA — which companies pay providers there.